Timothy Wright - 31 Dec 2023 Form 5 Insider Report for AGENUS INC (AGEN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
5
Accepted by SEC
12 Feb 2024, 07:00:10 UTC
Prior SEC filing
04 Oct 2023
Next SEC filing
04 Jan 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Christine Klaskin, as Attorney-in-Fact for Timothy R. Wright

Key filing fact

Timothy Wright filed Form 5 for AGENUS INC (AGEN) on 12 Feb 2024.

Key facts

  • This page summarizes Timothy Wright's Form 5 filing for AGENUS INC (AGEN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Feb 2024, 07:00.

Change

  • Previous filing in this sequence was filed on 04 Oct 2023.
  • Current net transaction value: +$4,400.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGEN transaction

Common Stock

Small acquisition under Rule 16a-6

Transaction value
$4,400
Shares
+5,000
Change %
+9.9%
Price
$0.8800
Shares after
55,391
Date
03 Nov 2023
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents open market purchase of common stock for cash.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .